11/26
09:17 am
asnd
Ascendis Pharma A/S (NASDAQ:ASND) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
Ascendis Pharma A/S (NASDAQ:ASND) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
11/20
06:01 am
asnd
Ascendis Pharma A/S (NASDAQ:ASND) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
Low
Report
Ascendis Pharma A/S (NASDAQ:ASND) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
11/20
06:01 am
asnd
Ascendis Pharma A/S (NASDAQ:ASND) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
Low
Report
Ascendis Pharma A/S (NASDAQ:ASND) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
11/18
09:02 am
asnd
Ascendis Pharma A/S (NASDAQ:ASND) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $220.00 price target on the stock.
Low
Report
Ascendis Pharma A/S (NASDAQ:ASND) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $220.00 price target on the stock.
11/18
09:02 am
asnd
Ascendis Pharma A/S (NASDAQ:ASND) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $220.00 price target on the stock.
Low
Report
Ascendis Pharma A/S (NASDAQ:ASND) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $220.00 price target on the stock.
11/18
09:00 am
asnd
Ascendis Pharma A/S (NASDAQ:ASND) is now covered by analysts at Wolfe Research. They set a "peer perform" rating and a $255.00 price target on the stock.
Low
Report
Ascendis Pharma A/S (NASDAQ:ASND) is now covered by analysts at Wolfe Research. They set a "peer perform" rating and a $255.00 price target on the stock.
11/18
09:00 am
asnd
Ascendis Pharma A/S (NASDAQ:ASND) is now covered by analysts at Wolfe Research. They set a "peer perform" rating and a $255.00 price target on the stock.
Low
Report
Ascendis Pharma A/S (NASDAQ:ASND) is now covered by analysts at Wolfe Research. They set a "peer perform" rating and a $255.00 price target on the stock.
11/18
08:54 am
asnd
Rating for ASND
Low
Report
Rating for ASND
11/18
08:54 am
asnd
Rating for ASND
Low
Report
Rating for ASND
11/17
04:19 pm
asnd
Ascendis Pharma initiated with an Outperform at Wolfe Research
Low
Report
Ascendis Pharma initiated with an Outperform at Wolfe Research
11/17
04:19 pm
asnd
Ascendis Pharma initiated with an Outperform at Wolfe Research
Low
Report
Ascendis Pharma initiated with an Outperform at Wolfe Research
10/18
07:31 am
asnd
Ascendis Pharma A/S (NASDAQ:ASND) was upgraded by analysts at Raymond James Financial, Inc. to a "strong-buy" rating.
Low
Report
Ascendis Pharma A/S (NASDAQ:ASND) was upgraded by analysts at Raymond James Financial, Inc. to a "strong-buy" rating.
10/17
11:30 am
asnd
Rating for ASND
Low
Report
Rating for ASND
10/17
11:30 am
asnd
Rating for ASND
Low
Report
Rating for ASND
10/17
08:46 am
asnd
Ascendis Pharma A/S (NASDAQ:ASND) is now covered by analysts at Raymond James Financial, Inc.. They set a "strong-buy" rating and a $271.00 price target on the stock.
Low
Report
Ascendis Pharma A/S (NASDAQ:ASND) is now covered by analysts at Raymond James Financial, Inc.. They set a "strong-buy" rating and a $271.00 price target on the stock.
10/16
04:07 pm
asnd
Ascendis Pharma initiated with a Strong Buy at Raymond James
Low
Report
Ascendis Pharma initiated with a Strong Buy at Raymond James
10/16
04:07 pm
asnd
Ascendis Pharma initiated with a Strong Buy at Raymond James
Low
Report
Ascendis Pharma initiated with a Strong Buy at Raymond James
10/13
09:15 am
asnd
Rating for ASND
Low
Report
Rating for ASND
10/9
08:49 am
asnd
Rating for ASND
Low
Report
Rating for ASND